Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso

<p>The experimental malaria vaccine ChAd63 MVA ME-TRAP previously showed protective efficacy against Plasmodium falciparum infection in Phase IIa sporozoite challenge studies in adults in the United Kingdom and in a Phase IIb field efficacy trial in Kenyan adults. However, it failed to demonst...

Detaylı Bibliyografya
Asıl Yazarlar:	Morter, R, Tiono, AB, Nébié, I, Hague, O, Ewer, K, Sirima, SB
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Frontiers Media 2022

Benzer Materyaller

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
Yazar:: Richard Morter, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
Yazar:: Tiono, AB, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
Yazar:: Alfred B Tiono, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants
Yazar:: Bliss, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
Yazar:: Kimani, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals.
Yazar:: Hodgson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
Yazar:: Ogwang, C, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
Yazar:: Caroline Ogwang, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP
Yazar:: Rampling, T, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals
Yazar:: Hodgson, SH, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP
Yazar:: Rampling, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure
Yazar:: Biswas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
Yazar:: Elias, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Hospital-based surveillance of severe paediatric malaria in two malaria transmission ecological zones of Burkina Faso
Yazar:: Alfred B. Tiono, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
Yazar:: Sumi Biswas, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.
Yazar:: Alphonse Ouédraogo, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
Yazar:: Mensah, V, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso
Yazar:: Alphonse Ouédraogo, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
Yazar:: Victorine A Mensah, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

A Phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS
Yazar:: De Barra, E, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.
Yazar:: Eoghan de Barra, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso
Yazar:: Diarra Amidou, ve diğerleri
Baskı/Yayın Bilgisi: (2012-05-01)

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans
Yazar:: Sheehy, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
Yazar:: Sheehy, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
Yazar:: Diarra Amidou, ve diğerleri
Baskı/Yayın Bilgisi: (2012-03-01)

Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods.
Yazar:: Alfred B Tiono, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

<it>Plasmodium falciparum </it>genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso
Yazar:: Konaté Amadou T, ve diğerleri
Baskı/Yayın Bilgisi: (2009-06-01)

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens
Yazar:: Nébié Issa, ve diğerleri
Baskı/Yayın Bilgisi: (2009-10-01)

Safety and Immunogenicity of the malaria vaccine candidate R21 adjuvanted with matrix-m1 in West African adult volunteers, Burkina Faso
Yazar:: Tiono, AB, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Malariometric Indices in the Context of Seasonal Malaria Chemoprevention in Children Aged 1.5 to 12 Years during the Period of High Malaria Transmission in the Suburban Area of Banfora, Burkina Faso
Yazar:: San M. Ouattara, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Haemoglobin variants and <it>Plasmodium falciparum</it> malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso
Yazar:: Bougouma Edith C, ve diğerleri
Baskı/Yayın Bilgisi: (2012-05-01)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
Yazar:: Sheehy, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
Yazar:: Sheehy, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo
Yazar:: Taiwo Ibinaiye, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Climate impact on malaria in northern Burkina Faso
Yazar:: Yves M. Tourre, ve diğerleri
Baskı/Yayın Bilgisi: (2017-11-01)

Implementation of Home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina Faso
Yazar:: Pagnoni Franco, ve diğerleri
Baskı/Yayın Bilgisi: (2008-10-01)

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso
Yazar:: Mariama K. Cherif, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

Force of Infection (FOI) and Multiplicity of Infection (MOI) in <i>Plasmodium falciparum</i> Infected Children Aged 1.5–12 Years Living in the Malaria Endemic Area of Banfora, Burkina Faso
Yazar:: Emilie S. Badoum, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Social perceptions of malaria and diagnostic-driven malaria treatment in Burkina Faso
Yazar:: Orokia Traore, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: a qualitative exploration of caregivers and community distributors’ perspectives
Yazar:: Kévin Lasmi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)